Biotech
-
4.7KIPIX Stock Gearing Up For A Major Move
IPIX Stock is gearing up for a major move after receiving a Pre-IND response from the FDA on its planned clinical trial. This...
-
4.6KRevive Therapeutics: Buy the Dip
Revive Therapeutics remains one of the most undervalued companies trading on the OTC Markets. We first covered Revive in September when shares...
-
6.7KHumanigen An Under The Radar COVID-19 Play
Humanigen is the Rodney Dangerfield of the Biotech world. The company just cannot get any respect. A big part is that many...
-
362AVXL Stock Ready To Make A Big Move
AVXL stock was a big winner for us here at Insider Financial back in 2015 when we caught the run from $1 to...
-
12.5KHandicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
-
366Inspyr Therapeutics (NSPX): A Monster Runner
Inspyr Therapeutics (NSPX) has turned into a monster runner and a massive win for our subscribers that got our alert last Friday....
-
262Northwest Bio About To Cross The Finish Line
It has been a long 13-year wait for shareholders of Northwest Bio, but top-line data is imminent. The database for the Phase...
-
20.3KENZC and BioClonetics: A Perfect Merger
President Trump’s hospitalization for COVID-19 has shed the spotlight on the most important aspect in the treatment of the coronavirus –...
-
282Innovation Pharmaceuticals: A Cheap COVID-19 Play
Innovation Pharmaceuticals is a small-cap biotech that we have covered here at Insider Financial beginning when it was originally Cellceutix Corp. ...
-
12.1K1All Eyes On CytoDyn Now That Trump Has COVID-19
Just now, markets are waking up to the news that President Donald Trump and First Lady Melanie have tested positive for COVID-19....